WASHINGTON D.C. (WVUE) - The U.S. House is expected to vote Wednesday on the "Steve Gleason Act."
As part of Gleason's advocacy in getting assistive technology into the hands of those suffering with ALS and related diseases, the U.S. Senate passed the Steve Gleason Act of 2015 in April.
If passed by the House and signed into law, the measure would make speech generating devices, like the one Gleason uses to communicate, available to patients through Medicare and Medicaid.
House Majority Whip Steve Scalise says he will push for the bill's passage.
Gleason, the former Saints special-teams player, was diagnosed in January 2011 with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease.
His triumphs in overcoming his physical limitations serve as an inspiration to many.
Gleason has also helped raise funds to provide leading-edge technology, equipment and services to other individuals with neuromuscular diseases or injuries.
In a joint effort with his family and friends, he started his Team Gleason advocacy group shortly after his diagnosis.
The organization's goal is to help those struggling with ALS to live productive lives by providing access to events and assistive technology.